Key facts
- This page summarizes George Poste's Form 4 filing for EXELIXIS, INC. (EXEL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Aug 2024, 19:22.
George Poste - 08 Aug 2024 Form 4 Insider Report for EXELIXIS, INC. (EXEL)
- Reporting relationship
- Director
- Issuer ticker
- EXEL
- Reported as of
- 08 Aug 2024
- Net transaction value
- -$906,865
- SEC form
- 4
- Accepted by SEC
- 12 Aug 2024, 19:22:34 UTC
- Prior SEC filing
- 04 Jun 2024
- Next SEC filing
- 05 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nina Ayer, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
George Poste filed Form 4 for EXELIXIS, INC. (EXEL) on 12 Aug 2024.
Change
- Previous filing in this sequence was filed on 04 Jun 2024.
- Current net transaction value: -$906,865.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXEL
transaction
Common Stock
Sale
- Transaction value
- $906,865
- Shares
- -33,725
- Change %
- -14%
- Price
- $26.89
- Shares after
- 199,020
- Date
- 08 Aug 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.86 to $26.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
Footnote F2
Includes 18,838 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock.